Auris Medical
Auris Medical develops novel pharmaceutical therapies to prevent and treat severe inner ear disorders.
Business Model:
Revenue: $0
Employees: 11-50
Industries / Tags:
Detailed Auris Medical Information
Geographic Data
Address:
City: Basel
State: Basel-Stadt
Zip:
Country: Switzerland
Financial Info
Stage:
post ipo debt
Raised Last:
$13M
Raised Total:$74M
Social
Metrics
1,879,451Website Global Rank
11,651Website Monthly Traffic
Twitter Followers
Description
They at Auris Medical are dedicated to developing novel pharmaceutical therapies to protect hearing, silence tinnitus and restore balance. Auris Medical is the leading pioneer in the emerging field of therapies for neurotologic disorders affecting the inner ear. They have two projects in advanced clinical development, Keyzilen® for the treatment of acute inner ear tinnitus and AM-111 for the treatment of acute inner ear hearing loss. In addition, they have AM-125 in early clinical development for the treatment of vertigo. They have additional projects under development and are further strengthening their pipeline through collaborations with leading academic institutions in this field.
Contact Phone:
Contact Email:
Auris Medical went public on 11/7/2014 on the FRA
Listed Exchange:
FRA
IPO Date:
11/7/2014
Ticker Symbol:
2RA1
Live
Opened: -/share
| EBITDA | - |
| Total Cash | - |
| Total Debt | - |
| Total Revenue | - |
| Total Profit (Gross) | - |
| PE Ratio | - |
| Announced Date | Company | Transaction | Money Raised |
|---|
| Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 4/2013 | Series C | 2 | $51M |
Sofinnova Partners Sofinnova Investments Sofinnova Investments Sofinnova Partners Sofinnova Partners Sofinnova Investments Sofinnova Investments Sofinnova Partners |
12/2007 | Series A | 1 | - |
Idinvest Partners Idinvest Partners Idinvest Partners Idinvest Partners |
7/2016 | Post-IPO Debt | 1 | $12.5M |
Hercules Capital Hercules Capital |
2/2008 | Series B | 3 | $10.1M |
ZKB Pharma Vision Fund Idinvest Partners Lacuna ZKB Pharma Vision Fund Idinvest Partners Lacuna |
12/2007 | Series A | 1 | - |
Idinvest Partners Idinvest Partners Idinvest Partners Idinvest Partners |
|---|
| Announced Date | Name | Price |
|---|---|---|
| 6/2021 | Trasir Therapeutics |
Employee Departments
Employee States
|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|
